Halozyme Therapeutics, a biopharmaceutical company, has commenced patient dosing in a Phase I clinical trial with PEGPH20 in cancer patients with refractory solid tumors. This multi-center, open-label, dose-escalation
Dr Seide has over 23 years of experience as a patent attorney, with the majority of it focused in the life sciences industry. Her experience encompasses all facets
The medication is a generic version of Wyeth’s Tazocin, an injectable antibiotic. Hospira will offer piperacillin/tazobactam as a powder for solution for injection or infusion in 2.25g and
The Phase II, double-blind, vehicle-controlled study will determine the efficacy, safety and tolerability of SRD441 in patients with atopic dermatitis (AD). Results from the Phase II study for
According to the company, the Capsule Neuron platform is a touch-enabled bedside device that can communicate wirelessly and features display of connectivity status at the point of care.
The decreased loss was primarily attributable to a $7.4 million decrease in R&D costs, the recognition in the 2008 period of the $5.94 million non-refundable license fee received
Revenue for the fiscal third quarter of 2009 was $75.31 million, an increase of 12%, compared to $67.03 million for the prior-year period. For the first nine months
According to Mayer Laboratories, the Today Sponge affords the freedom and flexibility of 24-hour contraceptive protection, and offers a safe and effective non-hormonal birth control alternative for women.
The company has appointed Ugo DeBlasi as its new CFO. In this position, Mr DeBlasi will provide leadership to the Celera finance, investor relations and information technology function,
On March 30, 2009, the FDA granted approval for a generic version of AstraZeneca’s Pulmicort Respules (budesonide inhalation suspension) to Apotex. The lawsuit follows Apotex’s indication of intent
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.